{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:33:28Z","timestamp":1789191208499,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T00:00:00Z","timestamp":1382313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.10.055","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T20:02:18Z","timestamp":1382990538000},"page":"119-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study"],"prefix":"10.1016","volume":"32","author":[{"given":"Elina O.","family":"Erra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Hervius","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Riutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Vene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kantele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.10.055_bib0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis \u2013 within our grasp","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0010","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0b013e32833c1d01","article-title":"Japanese encephalitis: update on vaccines and vaccine recommendations","volume":"23","author":"Wilder-Smith","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cid\/cis542","article-title":"Single dose of Vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines","volume":"55","author":"Erra","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0030","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2012.02.063","article-title":"Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine","volume":"30","author":"Woolpert","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0035","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0040","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4269\/ajtmh.2003.69.151","article-title":"Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan","volume":"69","author":"Ma","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0050","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid1411.080542","article-title":"Change in Japanese encephalitis virus distribution, Thailand","volume":"14","author":"Nitatpattana","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0055","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3201\/eid1712.110914","article-title":"Japanese encephalitis virus genotype replacement, Taiwan, 2009\u20132010","volume":"17","author":"Chen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0060","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1128\/JVI.00825-11","article-title":"Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia","volume":"85","author":"Pan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.1992.47.61","article-title":"A new genotype of Japanese encephalitis virus from Indonesia","volume":"47","author":"Chen","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0070","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1099\/0022-1317-81-10-2471","article-title":"Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain","volume":"81","author":"Williams","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1743-422X-8-449","article-title":"Emergence of Japanese encephalitis virus genotype V in the Republic of Korea","volume":"8","author":"Takhampunya","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cis883","article-title":"Crossprotective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes","volume":"56","author":"Erra","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0085","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies","volume":"99","author":"Russell","year":"1967","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0095","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0100","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","article-title":"Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0105","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO, IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.055_bib0110","unstructured":"Ixiaro: EPAR \u2013 Product Information. Updated 19\/04\/2013. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000963\/human_med_000862.jsp&mid=WC0b01ac058001d124 [accessed 01.07.13]."},{"key":"10.1016\/j.vaccine.2013.10.055_bib0115","unstructured":"The National Institute for Health and Welfare. Hanna Nohynek and Ulpu Elonsalo: Japanese encephalitis. Matkailijan terveysopas 2013 [in Finnish]. Updated 25\/03\/2013. http:\/\/www.terveyskirjasto.fi\/terveyskirjasto\/ktl.mat?p_artikkeli=mat00039 [Accessed 27.06.13]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T18:19:46Z","timestamp":1688581186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13014333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13014333"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}